CNN 6.25% 15.0¢ cardia bioplastics limited

interview: frank glatz, m.d. of cardia , page-7

  1. 8,256 Posts.
    Tony

    Good luck with a reply...

    ...some posters here (including me) do not get replies from Cardia, perhaps when the questions are too hard.

    The market does not like it when press releases and even statutory announcements miss informing on key profit performance data.

    This is why we don't see the SP reflect regular good news announcements.

    Regular good news on sales, contracts or serious trials should easily trigger a rerate, but it doesn't - this is because the market has no idea how much the company is profiting on this turnover.

    Lack of management response to holder requests for clarification in regard to profit is almost criminal - management are demonstrating negligence in their fiduciary duties here in respecting the rights of shareholders.


 
watchlist Created with Sketch. Add CNN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.